| scholarly article | Q13442814 |
| P50 | author | Christoph Handschin | Q14865377 |
| P2093 | author name string | Martin Weihrauch | |
| P2860 | cites work | The AMP-activated protein kinase--fuel gauge of the mammalian cell? | Q24315074 |
| Cloning, pharmacological characterization, and genomic localization of the human creatine transporter | Q24336176 | ||
| Intracellular compartmentation, structure and function of creatine kinase isoenzymes in tissues with high and fluctuating energy demands: the 'phosphocreatine circuit' for cellular energy homeostasis | Q24527330 | ||
| The peroxisome proliferator-activated receptor delta, an integrator of transcriptional repression and nuclear receptor signaling | Q24530668 | ||
| AMP kinase is required for mitochondrial biogenesis in skeletal muscle in response to chronic energy deprivation | Q24541475 | ||
| PGC-1 coactivators: inducible regulators of energy metabolism in health and disease | Q24541524 | ||
| mTOR signaling in growth control and disease | Q24634174 | ||
| AMPK and PPARdelta agonists are exercise mimetics | Q24652674 | ||
| Exercise induces transient transcriptional activation of the PGC-1alpha gene in human skeletal muscle | Q24657207 | ||
| Creatine Supplementation Increases Total Body Water Without Altering Fluid Distribution | Q24671938 | ||
| Citrulline/malate promotes aerobic energy production in human exercising muscle | Q24672673 | ||
| Coordinated reduction of genes of oxidative metabolism in humans with insulin resistance and diabetes: Potential role of PGC1 and NRF1 | Q24679555 | ||
| Complex Coordination of Cell Plasticity by a PGC-1α-controlled Transcriptional Network in Skeletal Muscle | Q26776167 | ||
| Caloric restriction and exercise "mimetics'': Ready for prime time? | Q26776446 | ||
| Skeletal muscle as an endocrine organ: PGC-1α, myokines and exercise | Q26785313 | ||
| A cold-inducible coactivator of nuclear receptors linked to adaptive thermogenesis | Q27860471 | ||
| Control of hepatic gluconeogenesis through the transcriptional coactivator PGC-1 | Q28216275 | ||
| Beta-hydroxy-beta-methylbutyrate supplementation in health and disease: a systematic review of randomized trials | Q28299062 | ||
| Metabolic control of muscle mitochondrial function and fatty acid oxidation through SIRT1/PGC-1alpha | Q28513388 | ||
| PGC-1alpha-responsive genes involved in oxidative phosphorylation are coordinately downregulated in human diabetes | Q29547229 | ||
| Transcriptional co-activator PGC-1 alpha drives the formation of slow-twitch muscle fibres | Q29555845 | ||
| mTOR controls mitochondrial oxidative function through a YY1-PGC-1alpha transcriptional complex | Q29617214 | ||
| Nuclear receptor expression links the circadian clock to metabolism | Q29622820 | ||
| PPARδ Promotes Running Endurance by Preserving Glucose | Q29792135 | ||
| Restoration of impaired nitric oxide production in MELAS syndrome with citrulline and arginine supplementation. | Q33887449 | ||
| Metabolic stress and altered glucose transport: activation of AMP-activated protein kinase as a unifying coupling mechanism | Q33907237 | ||
| Effects of beta-hydroxy-beta-methylbutyrate on muscle damage after a prolonged run. | Q33919492 | ||
| Effects of androgenic-anabolic steroids in athletes | Q33979780 | ||
| High-intensity training versus traditional exercise interventions for promoting health. | Q34101589 | ||
| Vitamin D status affects strength gains in older adults supplemented with a combination of β-hydroxy-β-methylbutyrate, arginine, and lysine: a cohort study | Q34205375 | ||
| Exercise metabolism and the molecular regulation of skeletal muscle adaptation | Q34326964 | ||
| Sustained activation of mTORC1 in skeletal muscle inhibits constitutive and starvation-induced autophagy and causes a severe, late-onset myopathy | Q34340407 | ||
| New peroxisome proliferator-activated receptor agonists: potential treatments for atherogenic dyslipidemia and non-alcoholic fatty liver disease | Q34398065 | ||
| Effectiveness of High-Intensity Interval Training (HIT) and Continuous Endurance Training for VO2max Improvements: A Systematic Review and Meta-Analysis of Controlled Trials. | Q34488279 | ||
| From molecular action to physiological outputs: peroxisome proliferator-activated receptors are nuclear receptors at the crossroads of key cellular functions | Q34494167 | ||
| Effect of oral creatine supplementation on human muscle GLUT4 protein content after immobilization | Q34512787 | ||
| Beta-hydroxy-beta-methylbutyrate supplementation and skeletal muscle in healthy and muscle-wasting conditions | Q34556525 | ||
| Overexpression of peroxisome proliferator-activated receptor gamma co-activator-1alpha leads to muscle atrophy with depletion of ATP | Q34571312 | ||
| Skeletal muscle-specific ablation of raptor, but not of rictor, causes metabolic changes and results in muscle dystrophy | Q34891582 | ||
| Effects of creatine supplementation and resistance training on muscle strength and weightlifting performance | Q35592400 | ||
| The coactivator PGC-1α regulates skeletal muscle oxidative metabolism independently of the nuclear receptor PPARβ/δ in sedentary mice fed a regular chow diet | Q36310530 | ||
| PGC-1α improves glucose homeostasis in skeletal muscle in an activity-dependent manner. | Q36477221 | ||
| Oral L-citrulline supplementation enhances cycling time trial performance in healthy trained men: Double-blind randomized placebo-controlled 2-way crossover study | Q36596357 | ||
| Impaired nitric oxide production in children with MELAS syndrome and the effect of arginine and citrulline supplementation | Q36759443 | ||
| The role of exercise and PGC1alpha in inflammation and chronic disease | Q36984669 | ||
| Paradoxical effects of increased expression of PGC-1alpha on muscle mitochondrial function and insulin-stimulated muscle glucose metabolism | Q37006469 | ||
| The role of mTOR signalling in the regulation of skeletal muscle mass in a rodent model of resistance exercise. | Q37160004 | ||
| Exploring the therapeutic role of creatine supplementation. | Q37404612 | ||
| Muscle PGC-1α modulates satellite cell number and proliferation by remodeling the stem cell niche. | Q37466207 | ||
| The biology of PGC-1α and its therapeutic potential | Q37484604 | ||
| Peroxisome proliferator-activated receptor gamma coactivator-1 promotes cardiac mitochondrial biogenesis | Q37526796 | ||
| Lack of adequate appreciation of physical exercise's complexities can pre-empt appropriate design and interpretation in scientific discovery | Q37590547 | ||
| Rapamycin: one drug, many effects | Q37679469 | ||
| The worldwide epidemiology of type 2 diabetes mellitus--present and future perspectives | Q37953791 | ||
| Duchenne and Becker muscular dystrophies. | Q38230979 | ||
| Systemic pan-AMPK activator MK-8722 improves glucose homeostasis but induces cardiac hypertrophy. | Q38399909 | ||
| Selective Chemical Inhibition of PGC-1α Gluconeogenic Activity Ameliorates Type 2 Diabetes. | Q38432412 | ||
| MELAS syndrome: Clinical manifestations, pathogenesis, and treatment options | Q38533544 | ||
| Concurrent exercise training: do opposites distract? | Q38923257 | ||
| Physiological adaptations to interval training and the role of exercise intensity | Q38982599 | ||
| Coregulator-mediated control of skeletal muscle plasticity - A mini-review | Q39069079 | ||
| Global and targeted gene expression and protein content in skeletal muscle of young men following short-term creatine monohydrate supplementation. | Q39100609 | ||
| "Nutraceuticals" in relation to human skeletal muscle and exercise | Q39112416 | ||
| Creatine supplementation increases glycogen storage but not GLUT-4 expression in human skeletal muscle. | Q39127116 | ||
| Pharmacological activation of PPARbeta/delta stimulates utrophin A expression in skeletal muscle fibers and restores sarcolemmal integrity in mature mdx mice | Q39801012 | ||
| AMPK activation stimulates myofibrillar protein degradation and expression of atrophy-related ubiquitin ligases by increasing FOXO transcription factors in C2C12 myotubes | Q40109932 | ||
| Rapamycin in mice | Q42262179 | ||
| The carbamido diacetyl reaction: a test for citrulline | Q42587245 | ||
| Suppression of beta cell energy metabolism and insulin release by PGC-1alpha | Q42799597 | ||
| Effect of creatine monohydrate in improving cellular energetics and muscle strength in ambulatory Duchenne muscular dystrophy patients: a randomized, placebo-controlled 31P MRS study. | Q43098109 | ||
| Citrulline malate enhances athletic anaerobic performance and relieves muscle soreness | Q43102240 | ||
| Creatine supplementation reduces skeletal muscle degeneration and enhances mitochondrial function in mdx mice | Q43818941 | ||
| Creatine supplementation combined with resistance training in older men. | Q43820496 | ||
| Adaptations of skeletal muscle to exercise: rapid increase in the transcriptional coactivator PGC-1. | Q44240302 | ||
| Beneficial effects of creatine supplementation in dystrophic patients | Q44411893 | ||
| No effect of creatine supplementation on human myofibrillar and sarcoplasmic protein synthesis after resistance exercise | Q44489673 | ||
| Cardiac-specific induction of the transcriptional coactivator peroxisome proliferator-activated receptor gamma coactivator-1alpha promotes mitochondrial biogenesis and reversible cardiomyopathy in a developmental stage-dependent manner | Q44730585 | ||
| Effect of beta-hydroxy-beta-methylbutyrate, arginine, and lysine supplementation on strength, functionality, body composition, and protein metabolism in elderly women | Q44856463 | ||
| Creatine monohydrate enhances strength and body composition in Duchenne muscular dystrophy | Q44907892 | ||
| The effect of creatine supplementation upon inflammatory and muscle soreness markers after a 30km race. | Q45014893 | ||
| Effects of nine weeks of beta-hydroxy-beta- methylbutyrate supplementation on strength and body composition in resistance trained men. | Q46040122 | ||
| Creatine monohydrate and resistance training increase bone mineral content and density in older men. | Q46534245 | ||
| β-Hydroxy-β-methylbutyrate free acid reduces markers of exercise-induced muscle damage and improves recovery in resistance-trained men. | Q46937455 | ||
| Serious cardiovascular side effects of large doses of anabolic steroids in weight lifters | Q47324002 | ||
| Mammalian target of rapamycin complex 2 regulates muscle glucose uptake during exercise in mice | Q48206210 | ||
| Adverse events of erythropoietin in long-term and in acute/short-term treatment | Q50122414 | ||
| Acute Citrulline-Malate Supplementation and High-Intensity Cycling Performance. | Q53199279 | ||
| Performance and muscle fiber adaptations to creatine supplementation and heavy resistance training. | Q54082255 | ||
| Quantitation of muscle glycogen synthesis in normal subjects and subjects with non-insulin-dependent diabetes by 13C nuclear magnetic resonance spectroscopy. | Q54332121 | ||
| Resistance exercise enhances the molecular signaling of mitochondrial biogenesis induced by endurance exercise in human skeletal muscle. | Q54568265 | ||
| Creatine in type 2 diabetes: a randomized, double-blind, placebo-controlled trial. | Q55053469 | ||
| PGC1α expression is controlled in skeletal muscles by PPARβ, whose ablation results in fiber-type switching, obesity, and type 2 diabetes | Q57848914 | ||
| Influence of exercise intensity and duration on biochemical adaptations in skeletal muscle | Q67256715 | ||
| Activity of citrulline malate on acid-base balance and blood ammonia and amino acid levels. Study in the animal and in man | Q68028301 | ||
| High rates of fatty acid oxidation during reperfusion of ischemic hearts are associated with a decrease in malonyl-CoA levels due to an increase in 5'-AMP-activated protein kinase inhibition of acetyl-CoA carboxylase | Q71892100 | ||
| Effects of citrulline supplementation on fatigue and exercise performance in mice | Q84932858 | ||
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 211-220 | |
| P577 | publication date | 2017-10-20 | |
| P1433 | published in | Biochemical Pharmacology | Q864229 |
| P1476 | title | Pharmacological targeting of exercise adaptations in skeletal muscle: Benefits and pitfalls | |
| P478 | volume | 147 |
| Q90933183 | Alleviation of paclitaxel-induced mechanical hypersensitivity and hyperalgesic priming with AMPK activators in male and female mice |
| Q53684513 | An aPPARent Functional Consequence in Skeletal Muscle Physiology via Peroxisome Proliferator-Activated Receptors. |
| Q92033421 | Indirect AMP-Activated Protein Kinase Activators Prevent Incision-Induced Hyperalgesia and Block Hyperalgesic Priming, Whereas Positive Allosteric Modulators Block Only Priming in Mice |
| Q92193402 | Pharmacological targeting of age-related changes in skeletal muscle tissue |
| Q92447261 | Pterostilbene Enhances Endurance Capacity via Promoting Skeletal Muscle Adaptations to Exercise Training in Rats |
Search more.